# Lavior, Inc. – FDA Inspection, Oct 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/lavior-inc/fc7becec-8ec3-4a99-9ec3-2bccf0c51acf
Source feed: FDA_Inspections

> FDA inspection 1070159 of Lavior, Inc., October 26, 2018. 6 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070159
- Company Name: Lavior, Inc.
- Inspection Date: 2018-10-26
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Florida District Office
- Citation Count: 6

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)

Company: https://www.keypedia.com/companies/lavior-inc/9e5a7d45-90cc-45fa-b9f8-29b34e105b61

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9